Furthermore, we verified our findings through immunohistochemical sections of tumor tissue, which indicated that TMEM45A knockdown could suppress the levels of p-AKT and p-mTOR, and the use of SC79 could attenuate the inhibitory effect of TMEM45A knockdown on the pathway (Fig. 4K). The gene discussed is TMEM45A; the disease is neoplasm.